OR WAIT null SECS
Janssen Research and Development
Joseph A. Albanese, director of Analytical Strategy and Compliance at Janssen Research and Development, LLC
August 27, 2025
The authors propose a streamlined, efficient approach to determining specification equivalence that starts with a paper-based assessment of the methods and progresses to a data assessment for the methods under evaluation.
December 30, 2024
In this first of a four-part series, the authors provide an introduction to a practical approach for establishing specification equivalence. The regulatory basis and compliance examples from FDA observations and warning letters are included to support the need for an effective process.
October 02, 2022
Awareness of recently implemented—or ongoing—advances by the pharmacopoeias can help biotherapeutic manufacturers remain compliant with current requirements.
September 02, 2020
Processes, people, and tools are needed to comply with the pharmacopoeia and approved drug product registrations.
March 15, 2020
This article details the more operational aspects of monograph submissions, answering the question of how to participate.
The authors present a case study with raw materials and excipients, where a consistent, cross-functional approach is needed to ensure the appropriate selection, sourcing, testing, and filing of the materials used to manufacture bio/pharmaceutical products in a global environment, ensuring compliance with applicable compendial and regulatory requirements.